Depression high in prostate cancer patients

Researchers have said that diagnosis and treatment should be key priorities because the consequences of undiagnosed anxiety and depression could mean that patients are less likely to adhere to treatment plans and more likely to experience adverse reactions to treatment.

In the first study to investigate the association specifically within prostate cancer, researchers conducted a meta-analysis which included data on close to 4500 men. 

They found that depression and anxiety was highest in patients who had yet to undergo treatment, lowest in patients undertaking treatment and rose again in patients who had completed treatment. 

The authors said screening for psychological morbidity in individuals most at risk for psychological morbidity, which may in part be related to their stage of treatment, is an important clinical objective as a way of enhancing clinical outcomes and patient quality of life. 

The associated side effects